Skip to content

Evaluation of the Efficacy of Oxygen Therapy and Clinical Feasibility of High Flow Nasal Cannula During Moderate and Deep Sedation in Pediatric Patients

Evaluation of the Efficacy of Oxygen Therapy and Clinical Feasibility of High Flow Nasal Cannula During Moderate and Deep Sedation in Pediatric Patients

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04852432
Enrollment
258
Registered
2021-04-21
Start date
2021-07-27
Completion date
2024-12-30
Last updated
2024-02-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pediatric Sedation

Brief summary

The investigators evaluate the efficacy and safety of routine administration of oxygen during moderate or deep sedation in pediatric patients. In addition, in terms of efficacy and safety, oxygen administration via nasal prong and high flow nasal cannula will be compared.

Interventions

DEVICEhigh flow nasal cannula

The heated air is administered at a rate of 2L/kg/min using an Optiflow device (Fisher and Paykel Healthcare, Auckland, New Zealand). Inhalation oxygen concentration starts with 50%.

Oxygen is administered via nasal prong

Sponsors

Seoul National University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
No minimum to 17 Years
Healthy volunteers
No

Inclusion criteria

* Children under the age of 18 who undergo moderate-deep sedation

Exclusion criteria

* Respiratory failure patients * Increased intracranial pressure * Recent massive nasal bleeding * History of airway surgery * Complete nasal obstruction * Pulmonary hypertension * Skull base fracture

Design outcomes

Primary

MeasureTime frameDescription
Desaturation (≤95%)through study completion, average 30 minutesOccurrence of desaturation (pulse oximeter ≤95%)

Secondary

MeasureTime frameDescription
Desaturation (≤90%)through study completion, average 30 minutesOccurrence of desaturation (pulse oximeter ≤90%)
CO2 valuethrough study completion, average 30 minutespercutaneous CO2 (maximum, minimum, mean values)
Minimum saturation during sedationthrough study completion, average 30 minutes
Complicationsthrough study completion, average 30 minutesAny complications during sedation

Countries

South Korea

Contacts

Primary ContactJin-Tae Kim, MD, PhD
jintae73@gmail.com02-2072-3661

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026